EQS-News: Fielmann Group AG
/ Key word(s): ESG/Rating
Fielmann Group awarded C+ Prime Status ESG rating in the Healthcare category ISS ESG, one of the most renowned rating companies for sustainable and responsible investments, has awarded the Fielmann Group a Prime Status ESG rating in the Healthcare category in an update published on October 8, 2024. Fielmann Group, a global provider of eyewear, acoustics and primary eyecare services, improved its ratings in all three categories (Environmental, Social, and Governance), compared with previous years, and for the first time earned a C+ Prime Status in the Healthcare category. A Prime Status ESG rating is a prerequisite for many sustainability-focused funds to invest in shares and thus enables a broader group of investors to invest in Fielmann shares. Fielmann also achieved a decile rank of 2 in the Healthcare category, which indicates its performance compared to other companies in the sector. A decile rank of 1 indicates a high relative performance, while a 10 indicates a low relative performance. “The Fielmann Group is a family business. Long-term success is only possible in a healthy society and a sustainable environment. Fielmann assumes responsibility for its customers, employees, society as well as the environment. We are delighted that our commitment to sustainability has been recognized and acknowledged,” said CFO Steffen Baetjer about the award. Hamburg, Germany – October 28, 2024 About Fielmann Group AG Further information
28.10.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
Language: | English |
Company: | Fielmann Group AG |
Weidestrasse 118 a | |
22083 Hamburg | |
Germany | |
Phone: | +49 40 270 76-0 |
Fax: | +49 40 270 76-390 |
Internet: | www.fielmann-group.com |
ISIN: | DE0005772206 |
WKN: | 577220 |
Indices: | SDAX |
Listed: | Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime Standard), Hamburg, Hanover, Munich, Stuttgart; Regulated Unofficial Market in Tradegate Exchange |
EQS News ID: | 2014501 |
End of News | EQS News Service |
|
2014501 28.10.2024 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.